Amneal Pharmaceuticals, Inc. Class A Common Stock AMRX
i
Market dataready · fetched 2026-11-11T14:38:30.942Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-11T14:36:12.559199241Z
FundamentalsSEC EDGAR · ready · as of 2026-09-30 · fetched 2026-11-11T14:38:29.294054+00:00
Amneal Pharmaceuticals, Inc. Class A Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 28.86 | 180.9% | 37.5% | 18.64 | 117.8% | 15.9% |
| 25Δ | 27.37 | 175.4% | 31.3% | 19.15 | 125.4% | 14.5% |
| 30Δ | 25.88 | 169.9% | 25.2% | 19.66 | 133.0% | 13.1% |
| 35Δ | 24.52 | 157.3% | 19.5% | 20.15 | 134.7% | 11.7% |
| 40Δ | 23.37 | 134.7% | 14.3% | 20.58 | 124.5% | 10.1% |
| 45Δ | 22.39 | 116.2% | 10.1% | 21.01 | 114.3% | 8.5% |
| 50Δ | 21.97 | 109.9% | 8.7% | 21.45 | 104.1% | 6.9% |
| 55Δ | 21.54 | 103.5% | 7.3% | 21.88 | 93.9% | 5.3% |
| 60Δ | 21.11 | 97.2% | 6.0% | 22.31 | 83.7% | 3.7% |
| 65Δ | 20.68 | 90.9% | 4.6% | |||
| 70Δ | 20.26 | 84.6% | 3.2% | |||
| 75Δ | 19.78 | 80.4% | 2.2% | |||
| 80Δ | 19.24 | 79.6% | 1.7% | |||
20Δ
- Pseudo strike
- 28.86
- IV
- 180.9%
- B/E move
- 37.5%
- Pseudo strike
- 18.64
- IV
- 117.8%
- B/E move
- 15.9%
25Δ
- Pseudo strike
- 27.37
- IV
- 175.4%
- B/E move
- 31.3%
- Pseudo strike
- 19.15
- IV
- 125.4%
- B/E move
- 14.5%
30Δ
- Pseudo strike
- 25.88
- IV
- 169.9%
- B/E move
- 25.2%
- Pseudo strike
- 19.66
- IV
- 133.0%
- B/E move
- 13.1%
35Δ
- Pseudo strike
- 24.52
- IV
- 157.3%
- B/E move
- 19.5%
- Pseudo strike
- 20.15
- IV
- 134.7%
- B/E move
- 11.7%
40Δ
- Pseudo strike
- 23.37
- IV
- 134.7%
- B/E move
- 14.3%
- Pseudo strike
- 20.58
- IV
- 124.5%
- B/E move
- 10.1%
45Δ
- Pseudo strike
- 22.39
- IV
- 116.2%
- B/E move
- 10.1%
- Pseudo strike
- 21.01
- IV
- 114.3%
- B/E move
- 8.5%
50Δ
- Pseudo strike
- 21.97
- IV
- 109.9%
- B/E move
- 8.7%
- Pseudo strike
- 21.45
- IV
- 104.1%
- B/E move
- 6.9%
55Δ
- Pseudo strike
- 21.54
- IV
- 103.5%
- B/E move
- 7.3%
- Pseudo strike
- 21.88
- IV
- 93.9%
- B/E move
- 5.3%
60Δ
- Pseudo strike
- 21.11
- IV
- 97.2%
- B/E move
- 6.0%
- Pseudo strike
- 22.31
- IV
- 83.7%
- B/E move
- 3.7%
65Δ
- Pseudo strike
- 20.68
- IV
- 90.9%
- B/E move
- 4.6%
- Pseudo strike
- IV
- B/E move
70Δ
- Pseudo strike
- 20.26
- IV
- 84.6%
- B/E move
- 3.2%
- Pseudo strike
- IV
- B/E move
75Δ
- Pseudo strike
- 19.78
- IV
- 80.4%
- B/E move
- 2.2%
- Pseudo strike
- IV
- B/E move
80Δ
- Pseudo strike
- 19.24
- IV
- 79.6%
- B/E move
- 1.7%
- Pseudo strike
- IV
- B/E move
Options history
Table
| Date | IV (%) |
|---|---|
| 80.24% | |
| 90.49% | |
| 148.41% | |
| 59.46% | |
| 54.62% | |
| 56.77% | |
| 63.18% | |
| 53.88% | |
| 51.60% | |
| 58.39% | |
| 61.96% | |
| 61.59% | |
| 50.95% | |
| 109.18% | |
| 56.72% | |
| 55.18% | |
| 55.00% | |
| 56.75% | |
| 56.41% | |
| 57.01% | |
| 63.32% | |
| 54.70% | |
| 56.39% | |
| 54.63% | |
| 58.73% | |
| 60.05% | |
| 64.81% | |
| 61.78% | |
| 68.65% | |
| 60.05% | |
| 55.94% | |
| 51.40% | |
| 55.58% | |
| 57.37% | |
| 59.56% | |
| 59.51% | |
| 54.13% | |
| 60.95% |
Drug Manufacturers - Specialty & Generic
ANIK
Anika Therapeutics, Inc., is a joint preservation company in the United States, Europe, and internationally. The company is headquartered in Bedford, Massachusetts.
More →ANIP
ANI Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, and markets brand-name and generic prescription pharmaceuticals in the United States and…
More →AQST
Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and marketing various products to address unmet medical needs in the United States and…
More →BCRX
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers oral and small molecule drugs. The company is headquartered in Durham, North Carolina.
More →BHC
Bausch Health Companies Inc. develops, manufactures and markets a range of pharmaceutical, medical device and over-the-counter (OTC) products primarily in the therapeutic areas of…
More →BIOA
Description unavailable
More →